<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04894695</url>
  </required_header>
  <id_info>
    <org_study_id>urine exo-LN</org_study_id>
    <nct_id>NCT04894695</nct_id>
  </id_info>
  <brief_title>Urine Exosomes to Identify Biomarkers for LN</brief_title>
  <official_title>Identification of Biomarkers for Lupus Nephritis Using Urine Exosomes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>RenJi Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>RenJi Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Urine exosomes will be extracted from patients with lupus nephritis, healthy controls, and&#xD;
      patients with systemic lupus erythematosus without lupus nephritis. Transcriptome and/or&#xD;
      metabonomics sequencing of exosomes will be performed to screen for molecules in the urine&#xD;
      exosomes of patients with lupus nephritis that are significantly different from those of the&#xD;
      other groups.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lupus nephritis is one of the most common complications of SLE, and its severity is closely&#xD;
      related to the prognosis of SLE. The gold standard for diagnosing lupus nephritis depends on&#xD;
      the pathological results of a kidney biopsy, which is invasive and may cause some damage to&#xD;
      the patient. Exosomes exist in almost all types of body fluids such as serum, urine and&#xD;
      cerebrospinal fluid, and contain a variety of genetic materials and proteins secreted by&#xD;
      cells, such as miRNA, lnRNA, cirRNA and metabolites, etc., which are potential substances&#xD;
      that can be used as biomarkers of diseases discovered in recent years. Urine exosomes are&#xD;
      easy to obtain and have no impact on patients' health, making them suitable for study as&#xD;
      disease biomarkers for lupus nephritis.&#xD;
&#xD;
      In this study, urine exosomes will be extracted from patients with lupus nephritis, healthy&#xD;
      controls, and patients with systemic lupus erythematosus without lupus nephritis.&#xD;
      Transcriptome and/or metabonomics sequencing of exosomes will be performed to screen for&#xD;
      molecules in the urine exosomes of patients with lupus nephritis that are significantly&#xD;
      different from those of the other groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 2, 2020</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>specific molecule levels in urine exosomes</measure>
    <time_frame>2 weeks</time_frame>
    <description>Molecule like miRNAs were determined in urine exosomes of different groups and the following validation will determine which molecule can be served as biomarkers of lupus nephritis</description>
  </primary_outcome>
  <number_of_groups>3</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Lupus Nephritis</condition>
  <arm_group>
    <arm_group_label>healthy control (HC)</arm_group_label>
    <description>healthy control</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Systemic Lupus Erythematosus (SLE)</arm_group_label>
    <description>Systemic Lupus Erythematosus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>lupus nephritis (LN)</arm_group_label>
    <description>lupus nephritis</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>biomarkers detection in different groups</intervention_name>
    <description>Biomarkers of urine exosomes in different groups were identified by sequencing technologyï¼Œthen biomarkers were validated using urine samples of different groups</description>
    <arm_group_label>Systemic Lupus Erythematosus (SLE)</arm_group_label>
    <arm_group_label>healthy control (HC)</arm_group_label>
    <arm_group_label>lupus nephritis (LN)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        community sample&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  No history of chronic or serious diseases such as cardiovascular disease, liver&#xD;
             disease, kidney disease, respiratory disease, blood disease, lymphatic disease,&#xD;
             endocrine disease, immune disease, mental disease, neuromuscular disease,&#xD;
             gastrointestinal system disease, etc.&#xD;
&#xD;
          -  General health condition is good;&#xD;
&#xD;
          -  Vital signs examination, physical examination, clinical laboratory examination (blood&#xD;
             routine, urine routine, blood biochemical examination, coagulation function&#xD;
             examination), electrocardiogram, and the results show normal or abnormal without&#xD;
             clinical significance&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Other rheumatic immune disease;&#xD;
&#xD;
          -  Abnormal liver and kidney function;&#xD;
&#xD;
          -  Acute and chronic infectious diseases.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Liangjing Lu</last_name>
    <role>Principal Investigator</role>
    <affiliation>RenJi Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Huijing Huang</last_name>
    <phone>86-18217720058</phone>
    <email>fangfeijin90@163.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Renji Hospital, Shanghai Jiaotong University School of Medicine</name>
      <address>
        <city>Shanghai</city>
        <zip>021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Liangjing Lu</last_name>
      <phone>86-13661472001</phone>
      <email>Lu_liangjing@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Zhao Y, Wei W, Liu ML. Extracellular vesicles and lupus nephritis - New insights into pathophysiology and clinical implications. J Autoimmun. 2020 Dec;115:102540. doi: 10.1016/j.jaut.2020.102540. Epub 2020 Sep 4. Review.</citation>
    <PMID>32893081</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 15, 2021</study_first_submitted>
  <study_first_submitted_qc>May 15, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 20, 2021</study_first_posted>
  <last_update_submitted>July 27, 2021</last_update_submitted>
  <last_update_submitted_qc>July 27, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nephritis</mesh_term>
    <mesh_term>Lupus Nephritis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

